Tapio Visakorpi

40.7k total citations · 6 hit papers
234 papers, 16.4k citations indexed

About

Tapio Visakorpi is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Tapio Visakorpi has authored 234 papers receiving a total of 16.4k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Pulmonary and Respiratory Medicine, 124 papers in Molecular Biology and 86 papers in Cancer Research. Recurrent topics in Tapio Visakorpi's work include Prostate Cancer Treatment and Research (118 papers), Prostate Cancer Diagnosis and Treatment (37 papers) and Cancer-related molecular mechanisms research (25 papers). Tapio Visakorpi is often cited by papers focused on Prostate Cancer Treatment and Research (118 papers), Prostate Cancer Diagnosis and Treatment (37 papers) and Cancer-related molecular mechanisms research (25 papers). Tapio Visakorpi collaborates with scholars based in Finland, United States and United Kingdom. Tapio Visakorpi's co-authors include Teuvo L.J. Tammela, Olli Kallioniemi, Jorma Isola, Kimmo Porkka, Outi R. Saramäki, Kati K. Waltering, Pasi A. Koivisto, Robert L. Vessella, Marika J. Linja and Christian Palmberg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Tapio Visakorpi

233 papers receiving 16.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

In vivo amplification of the androgen receptor gene and progression of human prostate cancer

1995 1.1k citations Tapio Visakorpi, Teuvo L.J. Tammela et al. profile →
MicroRNA Expression Profiling in Prostate Cancer

2007 758 citations Kimmo Porkka, Minja J. Pfeiffer et al. Cancer Research profile →
Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer.

2001 594 citations Marika J. Linja, Outi R. Saramäki et al. PubMed profile →
Changes in circulating microRNA levels associated with prostate cancer

2012 592 citations Tapio Visakorpi et al. profile →
Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer.

1997 545 citations Teuvo L.J. Tammela, Jorma Isola et al. PubMed profile →
Long Noncoding RNA in Prostate, Bladder, and Kidney Cancer

2013 526 citations Tapio Visakorpi et al. profile →

Peers

Countries citing papers authored by Tapio Visakorpi

Since Specialization

Citations

This map shows the geographic impact of Tapio Visakorpi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tapio Visakorpi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tapio Visakorpi more than expected).

Fields of papers citing papers by Tapio Visakorpi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tapio Visakorpi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tapio Visakorpi. The network helps show where Tapio Visakorpi may publish in the future.

Co-authorship network of co-authors of Tapio Visakorpi

This figure shows the co-authorship network connecting the top 25 collaborators of Tapio Visakorpi. A scholar is included among the top collaborators of Tapio Visakorpi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tapio Visakorpi. Tapio Visakorpi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long noncoding RNA EPCART regulates translation through PI3K/AKT/mTOR pathway and PDCD4 in prostate cancer 2024 ·Cancer Gene Therapy ·(unknown), (unknown), Janika Nättinen, Ulla Aapola, Pavlína Gregorová, Teuvo L.J. Tammela, Hannu Uusitalo, L. Peter Sarin, Tapio Visakorpi, Leena Latonen	2
2	Identification of long noncoding RNAs with aberrant expression in prostate cancer metastases 2023 ·Endocrine Related Cancer ·(unknown), (unknown), Elaheh Moradi, Hanna E. Rauhala, (unknown), William B. Isaacs, Matti Nykter, Teemu J. Murtola, Teuvo L.J. Tammela, Leena Latonen, G. Steven Bova, Juha Kesseli, Tapio Visakorpi	6
3	miR-32 promotes MYC-driven prostate cancer 2022 ·Oncogenesis ·Mauro Scaravilli, (unknown), (unknown), (unknown), Pekka Ruusuvuori, Tapio Visakorpi, Leena Latonen	11
4	Prostate cancer evolution from multilineage primary to single lineage metastases with implications for liquid biopsy 2020 ·Nature Communications ·Dan J. Woodcock, (unknown), Sinja Taavitsainen, Matti Kankainen, Gunes Gundem, Daniel Brewer, Pekka Ellonen, Maija Lepistö, (unknown), Andrew Warner, Teemu Tolonen, (unknown), William B. Isaacs, M R Emmert-Buck, Matti Nykter, Tapio Visakorpi, G. Steven Bova, David C. Wedge	42
5	Expression of neuroendocrine differentiation markers in lethal metastatic castration-resistant prostate cancer 2018 ·Pathology - Research and Practice ·(unknown), Tapio Visakorpi, Teemu Tolonen, Joanna Ilvesaro, G. Steven Bova	17
6	The expression of AURKA is androgen regulated in castration-resistant prostate cancer 2017 ·Scientific Reports ·Kati Kivinummi, Alfonso Urbanucci, Katri A. Leinonen, Teuvo L.J. Tammela, Matti Annala, William B. Isaacs, G. Steven Bova, Matti Nykter, Tapio Visakorpi	41
7	Differential impact of RB status on E2F1 reprogramming in human cancer 2017 ·Journal of Clinical Investigation ·Christopher McNair, Kexin Xu, Amy C. Mandigo, Matteo Benelli, Benjamin E. Leiby, Daniel Nava Rodrigues, Johan Lindberg, Henrik Grönberg, Mateus Crespo, Bram De Laere, Luc Dirix, Tapio Visakorpi, Fugen Li, Felix Y. Feng, Johann S. de Bono, Francesca Demichelis, Mark A. Rubin, Myles Brown, Karen E. Knudsen	70
8	miR-25 Modulates Invasiveness and Dissemination of Human Prostate Cancer Cells via Regulation of αv- and α6-Integrin Expression 2015 ·Cancer Research ·Eugenio Zoni, Geertje van der Horst, (unknown), (unknown), Jayant K. Rane, Rob C.M. Pelger, Anne T. Collins, Tapio Visakorpi, B. Ewa Snaar‐Jagalska, Norman J. Maitland, Gabri van der Pluijm	83
9	Transcriptome Sequencing Reveals PCAT5 as a Novel ERG-Regulated Long Noncoding RNA in Prostate Cancer 2015 ·Cancer Research ·Antti Ylipää, Kati Kivinummi, (unknown), Matti Annala, Leena Latonen, Mauro Scaravilli, Kimmo Kartasalo, (unknown), Serdar Karakurt, Janne Seppälä, Olli Yli‐Harja, Teuvo L.J. Tammela, Wei Zhang, Tapio Visakorpi, Matti Nykter	58
10	Hypermethylation of the GABRE∼miR-452∼miR-224 Promoter in Prostate Cancer Predicts Biochemical Recurrence after Radical Prostatectomy 2014 ·Clinical Cancer Research ·Helle Kristensen, Christa Haldrup, Siri H. Strand, Kamilla Mundbjerg, Martin M. Mortensen, Kasper Thorsen, Marie S. Ostenfeld, Peter J. Wild, Christian Arsov, Wolfgang Goering, Tapio Visakorpi, Lars Egevad, Johan Lindberg, Henrik Grönberg, S. Høyer, Michael Borre, Torben F. Ørntoft, Karina D. Sørensen	73
11	USP22 Regulates Oncogenic Signaling Pathways to Drive Lethal Cancer Progression 2013 ·Cancer Research ·Randy S. Schrecengost, Jeffry L. Dean, Jonathan F. Goodwin, Matthew J. Schiewer, Mark W. Urban, Timothy J. Stanek, Robyn T. Sussman, Jessica Hicks, Ruth Birbe, Rossitza Draganova‐Tacheva, Tapio Visakorpi, Angelo M. De Marzo, Steven B. McMahon, Karen E. Knudsen	99
12	HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk 2013 ·Cancer Epidemiology Biomarkers & Prevention ·Virpi H. Laitinen, Tiina Wahlfors, (unknown), Tommi Rantapero, Liisa M. Pelttari, Outi Kilpivaara, (unknown), Anne Kallioniemi, Heli Nevanlinna, Lauri A. Aaltonen, Robert L. Vessella, Anssi Auvinen, Tapio Visakorpi, Teuvo L.J. Tammela, Johanna Schleutker	65
13	Kliininen tutkimus Suomessa : tutkimuksen rakenteet 2012 ·Tampere University Institutional Repository (Tampere University) ·Tapio Visakorpi, Sirpa Jalkanen, Markku Laakso, Matti Lehto, Helena Liira, Markku Mäki, Jorma Penttinen, Ilkka Rauramo, Markku J. Savolainen, Tuulikki Sokka, Lasse Viinikka	1
14	[Are there enough medical scientists in Finland?]. 2011 ·PubMed ·Risto Renkonen, Johanna Björkroth, Otto Helve, Johanna Louhimo, Päivi Rautava, Anne M. Remes, Toni T. Seppälä, (unknown), Irma Virjo, Tapio Visakorpi, Markku Heikinheimo	1
15	Association of SPINK1 Expression and TMPRSS2:ERG Fusion with Prognosis in Endocrine-Treated Prostate Cancer 2010 ·Clinical Cancer Research ·Katri A. Leinonen, Teemu Tolonen, (unknown), Ulf‐Håkan Stenman, Teuvo L.J. Tammela, Outi R. Saramäki, Tapio Visakorpi	76
16	Increased Expression of Androgen Receptor Sensitizes Prostate Cancer Cells to Low Levels of Androgens 2009 ·Cancer Research ·Kati K. Waltering, Merja A. Helenius, Biswajyoti Sahu, (unknown), Marika J. Linja, Olli A. Jänne, Tapio Visakorpi	182
17	TMPRSS2 : ERG Fusion Identifies a Subgroup of Prostate Cancers with a Favorable Prognosis 2008 ·Clinical Cancer Research ·Outi R. Saramäki, (unknown), Paula Martikainen, Robert L. Vessella, Teuvo L.J. Tammela, Tapio Visakorpi	194
18	Transcription Factor Stat5 Synergizes with Androgen Receptor in Prostate Cancer Cells 2008 ·Cancer Research ·Shyh‐Han Tan, Ayush Dagvadorj, Feng Shen, Lei Gu, Zhiyong Liao, Junaid Abdulghani, Ying Zhang, Edward P. Gelmann, Tobias Zellweger, Zoran Čulig, Tapio Visakorpi, Lukas Bubendorf, Robert A. Kirken, James G. Karras, Marja T. Nevalainen	88
19	MicroRNA Expression Profiling in Prostate Cancer breakdown → 2007 ·Cancer Research ·Kimmo Porkka, Minja J. Pfeiffer, Kati K. Waltering, Robert L. Vessella, Teuvo L.J. Tammela, Tapio Visakorpi	758
20	Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients. 2003 ·PubMed ·Teemu T. Junttila, Matti Laato, Tero Vahlberg, Karl‐Ove Söderström, Tapio Visakorpi, Jorma Isola, Klaus Elenius	92

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact